A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Conditions: Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Stomach Neoplasms; Pancreatic Ductal Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma; Small Cell Lung Carcinoma Interventions: Drug: SGN-CEACAM5C Sponsors: Seagen Inc.; Sanofi Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer & Oncology | Carcinoma | Gastric (Stomach) Cancer | Gastroenterology | Non-Small Cell Lung Cancer | Pancreas | Pancreatic Cancer | Research | Study